Acute renal failure (ARF) can be defined as a sudden loss of renal function
and is a common and serious clinical problem. There are many causes of ARF
but the most common cause results from injury to the renal tubular epi-the
lial cells (RTECs). RTECs can be injured by schemia or by cytotoxic agents
and, once injured, can die by necrosis or apotosis. In general, necrosis oc
curs in response to any severe injury, which leads to the biochemical colla
pse of the cell. Milder forms of the same types of injury cause apoptosis.
At the cellular level there are fundamental differences between necrosis an
d apoptosis. Necrosis results from the additive effect of a number of indep
endent biochemical events that are activated by severe depletion of cell en
ergy stores. By contrast, apoptosis occurs via a coordinated, predictable a
nd pre-determined pathway. These biochemical differences between apoptosis
and necrosis have important therapeutic implications. Once a cell has been
severely injured, necrosis is difficult to prevent. By contrast, the apopto
tic pathway can potentially be modulated to maintain cell viability. The co
mponents of the apoptotic pathway that are potentially amenable to therapeu
tic modulation are discussed in detail in this review.